BRPI0507660A - imunoglobulinas anti-epcam - Google Patents

imunoglobulinas anti-epcam

Info

Publication number
BRPI0507660A
BRPI0507660A BRPI0507660-9A BRPI0507660A BRPI0507660A BR PI0507660 A BRPI0507660 A BR PI0507660A BR PI0507660 A BRPI0507660 A BR PI0507660A BR PI0507660 A BRPI0507660 A BR PI0507660A
Authority
BR
Brazil
Prior art keywords
immunoglobulin
human
administering
frequently
once
Prior art date
Application number
BRPI0507660-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Malte Peters
Mathias Locher
Nadja Prang
Cornelia Quadt
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Publication of BRPI0507660A publication Critical patent/BRPI0507660A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BRPI0507660-9A 2004-02-13 2005-02-09 imunoglobulinas anti-epcam BRPI0507660A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/778,915 US20050180979A1 (en) 2004-02-13 2004-02-13 Anti-EpCAM immunoglobulins
PCT/EP2005/001307 WO2005080428A2 (fr) 2004-02-13 2005-02-09 Immunoglobulines anti-epcam

Publications (1)

Publication Number Publication Date
BRPI0507660A true BRPI0507660A (pt) 2007-07-17

Family

ID=34838270

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507660-9A BRPI0507660A (pt) 2004-02-13 2005-02-09 imunoglobulinas anti-epcam

Country Status (24)

Country Link
US (3) US20050180979A1 (fr)
EP (2) EP1713830B1 (fr)
JP (1) JP5220315B2 (fr)
KR (1) KR101236224B1 (fr)
CN (1) CN1976951B (fr)
AT (1) ATE437186T1 (fr)
AU (1) AU2005215874B2 (fr)
BR (1) BRPI0507660A (fr)
CA (1) CA2555694C (fr)
DE (1) DE602005015544D1 (fr)
DK (1) DK1713830T3 (fr)
EA (1) EA011951B1 (fr)
ES (1) ES2328159T3 (fr)
HK (1) HK1096103A1 (fr)
IL (1) IL177069A (fr)
MX (1) MXPA06008942A (fr)
NO (1) NO339364B1 (fr)
NZ (1) NZ549125A (fr)
PL (1) PL1713830T3 (fr)
PT (1) PT1713830E (fr)
SI (1) SI1713830T1 (fr)
UA (1) UA87128C2 (fr)
WO (1) WO2005080428A2 (fr)
ZA (1) ZA200606083B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585974B1 (fr) 2003-01-24 2013-02-27 University of Utah Procedes permettant de predire le risque de mortalite en mesurant la longueur des telomeres
EP1981539B1 (fr) 2006-02-09 2014-07-23 Amgen Research (Munich) GmbH Traitement du cancer du sein metastatique
EP2041181B1 (fr) * 2006-06-08 2011-05-18 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibiteurs spécifiques de protéase et leur utilisation pour le traitement du cancer
EP1865001A1 (fr) * 2006-06-08 2007-12-12 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Inhibiteurs spécifiques de protéase et leur utilisation dans la thérapie de cancer
ES2367675T3 (es) * 2007-04-04 2011-11-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anticuerpo anti-epcam y usos del mismo.
CN102439171B (zh) 2008-12-22 2017-07-14 犹他大学研究基金会 单色多重定量pcr
CN102844443B (zh) * 2009-09-21 2014-08-06 保罗·沃尔菲什 用于甲状腺癌诊断和治疗的方法和组合物
EP2819695B1 (fr) * 2012-03-02 2018-06-27 Academia Sinica Anticorps anti-molécules d'adhérence cellulaire épithéliale (epcam) et leurs procédés d'utilisation
CN103387989B (zh) * 2012-09-24 2016-05-18 厦门大学 上皮细胞粘附分子的核酸适体EpCAM D及其制备方法
ES2762860T3 (es) 2013-05-22 2020-05-26 Telomere Diagnostics Inc Medidas de abundancia de telómeros cortos
CN103275226B (zh) * 2013-06-09 2017-08-29 中国科学技术大学 特异性抗人上皮细胞粘附分子（EpCAM）的单克隆抗体的制备、鉴定及应用
BR112017014116A2 (pt) 2014-12-30 2018-03-06 Telomere Diagnostics Inc pcr quantitativo multiplex
ES2873846T3 (es) * 2015-11-19 2021-11-04 Revitope Ltd Complementación de fragmento de anticuerpo funcional para un sistema de dos componentes para eliminación redirigida de células no deseadas
JP2019530431A (ja) 2016-07-26 2019-10-24 テッサ・セラピューティクス・プライベート・リミテッド キメラ抗原受容体
WO2020018964A1 (fr) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions et procédés pour réguler l'expression de récepteurs spécifiques à l'antigène

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
US7227002B1 (en) * 1997-04-14 2007-06-05 Micromet Ag Human antibodies that bind human 17-A1/EpCAM tumor antigen
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US7605238B2 (en) * 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
CN100503639C (zh) * 2001-05-03 2009-06-24 默克专利有限公司 重组肿瘤特异性抗体及其应用
US20030175268A1 (en) * 2002-01-11 2003-09-18 Saint-Remy Jean-Marie R. Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome
PL375064A1 (en) * 2002-05-20 2005-11-14 Abgenix, Inc. Treatment of renal carcinoma using antibodies against the egfr

Also Published As

Publication number Publication date
HK1096103A1 (en) 2007-05-25
EA011951B1 (ru) 2009-06-30
EP1713830A2 (fr) 2006-10-25
PT1713830E (pt) 2009-10-19
EA200601386A1 (ru) 2007-06-29
IL177069A (en) 2010-11-30
UA87128C2 (ru) 2009-06-25
NO20064136L (no) 2006-11-07
CA2555694C (fr) 2013-04-16
ATE437186T1 (de) 2009-08-15
MXPA06008942A (es) 2007-01-26
NO339364B1 (no) 2016-12-05
US20120294873A1 (en) 2012-11-22
KR20070009988A (ko) 2007-01-19
PL1713830T3 (pl) 2010-01-29
IL177069A0 (en) 2006-12-10
EP1713830B1 (fr) 2009-07-22
AU2005215874B2 (en) 2011-01-27
ZA200606083B (en) 2007-10-31
SI1713830T1 (sl) 2009-10-31
AU2005215874A1 (en) 2005-09-01
JP5220315B2 (ja) 2013-06-26
KR101236224B1 (ko) 2013-02-22
DE602005015544D1 (de) 2009-09-03
ES2328159T3 (es) 2009-11-10
WO2005080428A2 (fr) 2005-09-01
CN1976951A (zh) 2007-06-06
EP2107071A3 (fr) 2009-12-30
DK1713830T3 (da) 2009-10-12
CA2555694A1 (fr) 2005-09-01
EP2107071A2 (fr) 2009-10-07
US20070274982A1 (en) 2007-11-29
WO2005080428A3 (fr) 2005-11-10
CN1976951B (zh) 2012-03-14
JP2008500277A (ja) 2008-01-10
NZ549125A (en) 2008-09-26
US20050180979A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
ATE437186T1 (de) Anti-epcam-immunoglobuline
CY1110783T1 (el) Μονοκλωνικα αντισωματα κατα αυξητικου παραγοντα ηπατοκυτταρων
DK1684869T3 (da) Fremgangsmåde til terapi af B-celle-relaterede cancersygdomme
MXPA06003788A (es) Anticuerpos completamente humanos contra 4-1bb humano (cd137).
EA200970262A1 (ru) Композиции и способы, относящиеся к антителам к глюкагоновым рецепторам
ZA200508389B (en) Humanized antibodies to interferon alpha receptor-1(IFNAR-1)
ATE455127T1 (de) Humane anti-humane cd3-bindungsmoleküle
ATE470676T1 (de) Anti-vegf-2 antikörper
MY145042A (en) Humanized monoclonal antibodies to hepatocyte growth factor
WO2003076585A3 (fr) Modulation controlee de la longueur de chaine laterale des acides amines des antigenes peptides
CY1109817T1 (el) Ολιγο-βητα-(1,3)-γλυκανη και μονοκλωνικα αντισωματα εναντιον καρκινου
DE60306505D1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
ATE364396T1 (de) Behandlung von pilzinfektion mit polyenen oder beta glucan synthese hemmern kombiniert mit anti- hsp antikörpern
TW200517124A (en) Fully human antibodies against human 4-1BB
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
DK1411962T3 (da) Terapi for pancreacancer med monoklonalt stof
SG156658A1 (en) Treatment of diseases
WO2003097082A3 (fr) Traitement de la maladie de crohn ou du psoriasis a partir d'anticorps anti-interferon gamma
CY1116887T1 (el) Anti-cd19 αντισωματα και χρησεις στην ογκολογια

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: MICROMET AG (DE)

Free format text: A FIM DE ATENDER AS ALTERACOES DE NOME REQUERIDAS ATRAVES DA PETICAO NO 20120113065/RJ, DE 06/12/2012, E NECESSARIO APRESENTAR MAIS UMA GUIA RELATIVA A SEGUNDA ALTERACAO DE NOME, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25D Requested change of name of applicant approved

Owner name: MICROMET GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: AMGEN RESEARCH (MUNICH) GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL